Search Results for: TMEM97

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel ADCYAP1R1 ADCYAP receptor type I
  • NGF-independant TRKA activation
  • G alpha (s) signalling events
  • Glucagon-type ligand receptors
  • ADORA2B mediated anti-inflammatory cytokines production
Novel CRLF3 cytokine receptor like factor 3
Novel ERAL1 Era like 12S mitochondrial rRNA chaperone 1
  • Mitochondrial translation initiation
  • Mitochondrial translation elongation
  • Mitochondrial translation elongation
  • Mitochondrial translation termination
Novel ORC1 origin recognition complex subunit 1
  • E2F-enabled inhibition of pre-replication complex formation
  • Activation of ATR in response to replication stress
  • Assembly of the ORC complex at the origin of replication
  • CDC6 association with the ORC:origin complex
  • CDT1 association with the CDC6:ORC:origin complex
  • Assembly of the pre-replicative complex
  • Orc1 removal from chromatin
  • Activation of the pre-replicative complex
  • G1/S-Specific Transcription
  • Patella dysplasias, including: Small patella syndrome (SPS); Nail-patella syndrome; Ear-patella-short statute syndrome
Novel POLDIP2 DNA polymerase delta interacting protein 2
Novel RNF167 ring finger protein 167
Novel TADA1 transcriptional adaptor 1
  • HATs acetylate histones
Novel TBC1D29P TBC1 domain family member 29, pseudogene
Novel UTP4 UTP4 small subunit processome component
  • rRNA modification in the nucleus and cytosol
  • Major pathway of rRNA processing in the nucleolus and cytosol
  • Familial cholestasis, including: Progressive familial intrahepatic cholestasis (PFIC); Benign recurrent intrahepatic cholestasis (BRIC); Intrahepatic cholestasis of pregnancy (ICP); North American Indian childhood cirrhosis (NAIC)
APP amyloid beta precursor protein
  • Platelet degranulation
  • ECM proteoglycans
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • Lysosome Vesicle Biogenesis
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • The NLRP3 inflammasome
  • Advanced glycosylation endproduct receptor signaling
  • Advanced glycosylation endproduct receptor signaling
  • Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
  • Post-translational protein phosphorylation
  • TRAF6 mediated NF-kB activation
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Purinergic signaling in leishmaniasis infection
  • Amyloid fiber formation
  • Deferoxamine
  • Aluminium
  • Zinc
  • L-methionine (R)-S-oxide
  • Resveratrol
  • Tromethamine
  • Phenserine
  • Tetrathiomolybdate
  • CAD106
  • Mito-4509
  • Edonerpic
  • Dimercaprol
  • Copper
  • Florbetaben (18F)
  • Florbetapir (18F)
  • Flutemetamol (18F)
  • Zinc acetate
  • Aluminium phosphate
  • Aluminum acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Alzheimer's disease (AD)
AQP12B aquaporin 12B
AQP2 aquaporin 2
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • Passive transport by Aquaporins
  • Congenital nephrogenic diabetes insipidus (NDI)
AQP6 aquaporin 6
  • Passive transport by Aquaporins
ARL13B ADP ribosylation factor like GTPase 13B
  • ARL13B-mediated ciliary trafficking of INPP5E
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • Aggrephagy
  • Aggrephagy
  • Joubert syndrome
ASZ1 ankyrin repeat, SAM and basic leucine zipper domain containing 1
  • PIWI-interacting RNA (piRNA) biogenesis
ATP6AP2 ATPase H+ transporting accessory protein 2
  • Metabolism of Angiotensinogen to Angiotensins
  • Neutrophil degranulation
  • Syndromic X-linked mental retardation with epilepsy or seizures, including: West syndrome (WS); Partington syndrome (PRTS); Proud syndrome (ACCAG); XMR and epilepsy (XMRE); MRXHF1; XMR OPHN1-related (MRXSO) ; XELBD; XMR, Christianson type (MRXSC); Creatine deficiency syndrome (XL-CDS); Renpenning syndrome (RENS1); Epilepsy and mental retardation limited to females (EFMR); Periventricular nodular heterotopia (PVNH); Hydrocephalus (XLH); XMR, JARID1C related (MRXSJ); Boerjeson-Forssman syndrome (BFLS); CK syndrome (CKS)
BCL2L13 BCL2 like 13
BIK BCL2 interacting killer
CD53 CD53 molecule
  • Neutrophil degranulation
CD74 CD74 molecule
  • Cell surface interactions at the vascular wall
  • MHC class II antigen presentation

Page 1 out of 4 pages